For years, PCOS has stood for Polycystic Ovary Syndrome. But (about a week ago) in May 2026, a global consensus process published in The Lancet recommended a new name: Polyendocrine Metabolic Ovarian Syndrome, or PMOS.
At first glance, this might sound like “just a name change.”
But for many patients, and for us as naturopathic doctors, this change is actually a big deal.
The old name made PCOS sound like a condition mostly about the ovaries — and specifically about ovarian “cysts.” But this has never been the full picture. What we have historically called PCOS is not simply an ovarian condition. It is a complex hormonal and metabolic condition that can affect the whole body.
The new name, PMOS, does a much better job describing what is actually happening.
Why Was PCOS Renamed PMOS?
The name Polycystic Ovary Syndrome has been misleading for a long time.
First, the “cysts” seen in PCOS are not usually true pathological cysts. They are typically small ovarian follicles, also called antral follicles. This distinction matters because many patients hear the word “cyst” and understandably worry that they have dangerous ovarian cysts or a condition that is only affecting their ovaries.
Second, not every patient with this condition has classic “polycystic ovaries” on ultrasound. Some patients have very clear symptoms of androgen excess, irregular ovulation, insulin resistance, acne, hair growth, or metabolic concerns — even without classic ultrasound findings.
Third, the old name made it easier for the condition to be treated as mainly a gynecologic or fertility issue.
That framing has caused many patients to be told things like:
“You only need to worry about it when you want to get pregnant.”
“Just go on birth control.”
“Your ultrasound looks normal, so you don’t have PCOS.”
“Just lose weight.”
But PMOS is not just about fertility. It is not just about periods. It is not just about the ovaries.
It is a whole-body endocrine and metabolic condition.
What Does PMOS Mean?
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome.
Here’s what that means in plain language:
Polyendocrine means multiple hormone systems may be involved.
Metabolic means the condition can affect how the body handles blood sugar, insulin, cholesterol, energy, inflammation, and long-term disease risk.
Ovarian recognizes that ovulation, menstrual cycles, and ovarian hormone patterns can still be part of the condition.
The benefit of the new name is that it keeps the ovarian piece, but it no longer makes the ovaries sound like the whole story.
That is a much more accurate and patient-centered way to describe this condition.
Why the Metabolic Piece Matters So Much
One of the most important parts of the PMOS name is the word metabolic.
Metabolic health refers to how well your body manages things like blood sugar, insulin, cholesterol, energy, inflammation, and long-term cardiovascular risk.
For many patients with PMOS, insulin resistance is a major part of the picture. Insulin is a hormone that helps move glucose, or sugar, from the bloodstream into the cells so the body can use it for energy.
When the body becomes insulin resistant, the cells do not respond to insulin as well. In response, the pancreas may make more insulin to keep blood sugar stable. This is called hyperinsulinemia, which simply means “higher insulin levels.”
This matters because insulin does more than affect blood sugar. In PMOS, higher insulin levels can also contribute to higher androgen activity. Androgens are hormones like testosterone. When androgen levels are elevated, or when the body is more sensitive to them, patients may notice symptoms like acne, facial hair growth, scalp hair thinning, irregular ovulation, longer cycles, or fertility challenges. The Endocrine Society notes that insulin resistance or elevated insulin levels may worsen androgen excess in PCOS/PMOS.
How Insulin Can Drive Androgen Excess
Insulin can increase androgen activity in several ways.
First, insulin can directly stimulate the ovaries to make more androgens. More specifically, insulin can work together with luteinizing hormone, or LH, to stimulate ovarian theca cells, which are cells involved in androgen production. Research has shown that insulin can act directly through insulin receptors on theca cells and influence androgen production.
Second, insulin can lower sex hormone-binding globulin, also called SHBG. SHBG is a carrier protein made by the liver. One of its jobs is to bind hormones like testosterone in the bloodstream. When SHBG is lower, there is often more free testosterone, which is the more active, bioavailable form of testosterone. That can make androgen-related symptoms more noticeable.
Third, insulin may also affect androgen production outside the ovaries, including the adrenal glands and adipose tissue. In plain language, that means androgen excess is not always coming from one single place. It can involve the ovaries, adrenal signaling, fat tissue, and broader metabolic hormone patterns.
This is one reason PMOS is a better name than PCOS. The old name made it sound like the ovaries were the whole problem. The newer name better reflects that the ovaries are often part of a bigger endocrine and metabolic pattern.
Androgens Can Also Worsen Insulin Resistance
The relationship between insulin and androgens goes both directions.
Insulin resistance can worsen androgen excess, but androgen excess can also worsen insulin resistance.
Higher androgen activity may contribute to more abdominal or visceral fat storage, which can worsen insulin resistance. Androgens may also affect how cells respond to insulin. This can create a frustrating loop:
Insulin resistance can increase androgen activity.
Higher androgen activity can worsen insulin resistance.
Then insulin levels may rise further, continuing the cycle.
This cycle helps explain why PMOS symptoms can feel so stubborn for some patients. It is not just a period issue. It is not just an ovary issue. It is often a hormone-metabolism feedback loop.
Why This Matters Clinically
Understanding this insulin-androgen cycle changes the way we think about care.
If insulin resistance is part of the picture, then improving insulin sensitivity may help support healthier androgen levels, more regular ovulation, improved cycle patterns, and better long-term metabolic health.
This is why PMOS care often needs to include more than cycle regulation alone. A more complete plan may include nutrition, blood sugar support, strength training, sleep support, stress physiology, targeted supplementation when appropriate, and medications such as metformin when clinically indicated.
The 2023 International Evidence-Based Guideline recommends that PCOS/PMOS care address reproductive, metabolic, cardiovascular, dermatologic, sleep, and psychological features across the lifespan. It also emphasizes metabolic risk assessment, not just reproductive symptoms.
This is also why patients in smaller bodies still deserve metabolic screening. Insulin resistance can be present even when BMI does not appear elevated, so it is important not to assume that metabolic risk only matters for patients in larger bodies.
The bigger takeaway is this:
PMOS is not simply about having irregular periods or ovarian follicles on ultrasound. It is often about how hormones, insulin, inflammation, ovulation, and metabolism are interacting — and that bigger picture deserves to be evaluated.
PMOS Can Affect More Than Your Cycle
PMOS can look different from person to person.
Some patients primarily notice cycle changes. Others are more bothered by acne, hair growth, blood sugar issues, fatigue, weight changes, or fertility challenges.
Common PMOS-related concerns can include:
- Irregular periods
- Skipped periods
- Long cycles
- Acne
- Facial hair growth
- Hair thinning
- Difficulty ovulating
- Fertility challenges
- Insulin resistance
- Blood sugar changes
- Weight changes or difficulty losing weight
- Higher risk of type 2 diabetes
- Cholesterol changes
- Sleep apnea
- Anxiety
- Depression
The 2023 International Evidence-Based Guideline also emphasizes that PCOS/PMOS care should address reproductive, metabolic, cardiovascular, dermatologic, sleep, and psychological features across the lifespan.
That is exactly why this rename matters.
It helps move the conversation from “What do the ovaries look like?” to “What is happening in the whole body?”
Does the PMOS Name Change Mean the Diagnostic Criteria Changed?
No. The name change does not mean that the diagnostic criteria have changed.
Current diagnosis still follows the 2023 International Evidence-Based Guideline for PCOS. For adults, diagnosis generally requires two out of three of the following, after other possible causes are ruled out:
1. Hyperandrogenism
This means elevated androgen activity.
It can show up clinically as:
- Acne
- Facial hair growth
- Excess body hair growth
- Scalp hair thinning
It can also show up on bloodwork as elevated total or free testosterone, DHEA-S, or other androgen markers.
2. Ovulatory Dysfunction
This means ovulation is not happening regularly.
It may look like:
- Cycles shorter than 21 days
- Cycles longer than 35 days
- Skipped periods
- Fewer than 8 cycles per year
3. Polycystic Ovarian Morphology or Elevated AMH
This can be seen on ultrasound or reflected by elevated anti-Müllerian hormone, also called AMH.
One important 2023 update is that AMH can be used as an alternative to ultrasound in adults. However, AMH is not meant to be used as a stand-alone test without the rest of the clinical picture.
Another important point: if someone has both irregular cycles and hyperandrogenism, ultrasound or AMH is not always required for diagnosis.
For adolescents, the criteria are different. Teens need both hyperandrogenism and ovulatory dysfunction, and ultrasound or AMH are not recommended for diagnosis because they are less specific during adolescence.
→ What you’ll notice here if you’re paying attention is that the metabolic/insulin resistance component is missing from the diagnostic criteria. The consequence of this not being a major part of diagnostic criteria is that it has the potential to be overlooked. With a naturopathic doctor on board, you can rest well assured that while this isn’t necessarily part of the diagnostic criteria, it’s part of your overall picture and will certainly be addressed.
Why This Name Change Can Help Patients Feel Less Dismissed
Many patients with PCOS have felt dismissed for years.
Some were told their symptoms were “normal.”
Some were only offered birth control without further evaluation.
Some were told to come back only when they wanted to get pregnant.
Some were told they did not have PCOS because their ultrasound did not show the expected ovarian pattern.
Others were diagnosed based on ultrasound alone, without a deeper conversation about insulin, androgens, ovulation, inflammation, or long-term metabolic risk.
The PMOS name helps validate what patients have been saying for a long time:
“This is affecting more than my ovaries.”
And they are right.
A better name will not fix the entire healthcare experience overnight. But language matters. When the name of a condition is more accurate, it can help guide better screening, better education, better research, and better care.
What a Whole-Body PMOS Evaluation Can Include
At Natural Medicine of Denver, we appreciate this name change because it reflects the way we already think about this condition: as a whole-body hormonal and metabolic pattern that deserves individualized care.
A more complete PMOS evaluation may include looking at:
- Menstrual cycle patterns
- Signs of androgen excess, like acne or hair growth
- Ovulation patterns
- Fertility goals
- Fasting insulin and blood sugar markers
- A1c
- Cholesterol and triglycerides
- Inflammation
- Thyroid health
- Adrenal and stress patterns
- Sleep quality
- Mood and mental health
- Nutrition and protein intake
- Exercise, strength training, and muscle mass
- Family history of diabetes or cardiovascular disease
The goal is not just to put a new label on symptoms. The goal is to understand what is driving the symptoms and create a plan that supports the patient’s whole health.
PMOS Is Not Your Fault
This is important: PMOS is not a personal failure.
It is not caused by laziness.
It is not simply about weight.
It is not because someone is “not trying hard enough.”
PMOS is a complex endocrine and metabolic condition. Lifestyle can absolutely be a powerful part of care, but patients deserve more than generic advice to eat less and exercise more.
They deserve a thoughtful plan that considers their symptoms, labs, goals, nervous system, nutrition, cycle patterns, metabolic health, and long-term risks.
Final Thoughts
The shift from PCOS to PMOS is more than a terminology update.
It is a step toward more accurate, compassionate, and effective care.
By recognizing the metabolic and whole-body nature of this condition, PMOS gives patients and providers a better framework for understanding what is really happening.
Hopefully, this change will help more patients get diagnosed earlier, feel less dismissed, and receive care that supports not only their cycles and fertility, but also their long-term metabolic, hormonal, and cardiovascular health.
If you have been diagnosed with PCOS in the past, or you are wondering whether PMOS may be part of your health picture, you deserve care that looks beyond the ovaries.
At Natural Medicine of Denver, we help patients understand the full hormonal and metabolic picture — including cycles, ovulation, insulin resistance, blood sugar, inflammation, skin symptoms, fertility goals, and long-term health.
If you are dealing with irregular cycles, acne, hair growth, fertility challenges, blood sugar concerns, or symptoms that have been brushed off in the past, we would be happy to talk with you.
Schedule a complimentary 15-minute introduction call to learn more about working with our team at Natural Medicine of Denver.
FAQs
What does PMOS stand for?
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. It is the new name for the condition previously called PCOS, or Polycystic Ovary Syndrome.
Why was PCOS renamed PMOS?
PCOS was renamed PMOS because the old name was misleading. It made the condition sound mainly related to ovarian cysts, even though the condition often involves multiple hormone systems, insulin resistance, metabolic health, ovulation, skin, mood, and long-term health risks.
Are ovarian “cysts” required to have PMOS?
No. Ovarian “cysts” are not required for diagnosis. In fact, the ovarian findings historically associated with PCOS are usually small follicles, not dangerous cysts. Diagnosis is based on a combination of androgen symptoms or labs, ovulatory dysfunction, and ovarian morphology or AMH, depending on the patient’s age and presentation.
Did the diagnostic criteria change when PCOS became PMOS?
No. The name changed, but the diagnostic criteria did not change. Current diagnosis still follows the 2023 International Evidence-Based Guideline.
Is PMOS only a fertility condition?
No. PMOS can affect fertility and ovulation, but it is not only a fertility condition. It can also involve insulin resistance, blood sugar changes, acne, hair growth, scalp hair thinning, cholesterol changes, sleep apnea, anxiety, depression, and long-term metabolic health.
What is the connection between PMOS and insulin resistance?
Many patients with PMOS have some degree of insulin resistance. When the body has trouble responding to insulin, insulin levels may rise. Higher insulin levels can worsen androgen activity, which may contribute to acne, hair growth, irregular ovulation, and cycle changes.
Can someone have PMOS even if their ultrasound is normal?
Yes. A person can still meet criteria for PMOS if they have irregular ovulation and hyperandrogenism, even without ultrasound findings. In those cases, ultrasound or AMH may not be required for diagnosis.
How is PMOS treated?
PMOS care should be individualized. A whole-body plan may include nutrition, exercise, blood sugar support, insulin-sensitivity support, stress and sleep support, cycle tracking, targeted supplements when appropriate, and medications when needed. The right approach depends on the patient’s symptoms, labs, goals, and medical history.
Should I still search for PCOS or PMOS?
During the transition, both terms will likely be used. Patients may still see PCOS in older articles, lab notes, insurance documents, or medical records. PMOS is the newer, more accurate name, but PCOS will likely remain familiar for some time.
Sources & References
- Teede HJ, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. Published May 12, 2026.
- Endocrine Society. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. Published May 12, 2026.
- Teede HJ, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism. 2023.
- American Society for Reproductive Medicine. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. 2023.
- Monash University. International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome: 2023 Guideline Summary. 2023.
- World Health Organization. Polycystic ovary syndrome. Updated January 22, 2026.
- Mayo Clinic. Polycystic ovary syndrome — Symptoms and causes. Updated April 21, 2026.
- Cleveland Clinic. Polyendocrine Metabolic Ovarian Syndrome / Polycystic Ovary Syndrome. Medically reviewed February 15, 2023.
- Contemporary OB/GYN. Global consensus renames PCOS to Polyendocrine Metabolic Ovarian Syndrome.Published May 2026.
